University of Botswana researcher Dr Norman Carl Swart has been named among the inaugural recipients of a highly competitive continental microgrant jointly awarded by the African Organization for Research and Training in Cancer AORTIC and Bio Usawa. This recognition marks a significant milestone for Botswana’s contribution to Africa-led cancer research and highlights the growing impact of local expertise on continental health challenges. Dr Swart was selected as part of the 2025-2026 cohort of early and mid-career researchers recognised for driving innovation in cancer care systems across Africa. The programme attracted over 150 applicants from across the continent, with only five researchers selected to represent Botswana, Zambia, Burkina Faso, Nigeria, and Kenya. Dr Swart’s award underscores both the quality of research emerging from Botswana and the importance of supporting locally led initiatives that address Africa’s unique healthcare needs.
The award-winning project led by Dr Swart brings together a multidisciplinary team from the University of Botswana’s Faculties of Health Sciences, Social Sciences, and Education Sports Science. The team comprises Dr Keitumetse Masisi, Dr Pearl Lefadola, Dr Malebogo Monnaatsie, Dr Tumelo Kgolo, and Professor Mpho Keetile, reflecting an integrated approach that combines health, social, and behavioural sciences to tackle challenges in cancer care. Their collaborative research focuses on strengthening care delivery systems and improving patient outcomes through evidence-based interventions. By drawing on multiple disciplines, the team aims to generate context-specific solutions that can inform policy and practice at both national and regional levels. The project exemplifies the University of Botswana’s commitment to interdisciplinary research that addresses pressing development challenges while enhancing scientific capacity within the country.
The microgrant programme, spearheaded by AORTIC and Bio Usawa, is designed to support locally driven research initiatives that strengthen equitable cancer care delivery across Africa. Beyond financial support, recipients gain access to international platforms to present findings at conferences and publish in leading academic journals, including the AORTIC Journal. Bio Usawa co-founder and CEO Dr Menghis Bairu emphasized that investing in African researchers is critical to addressing the continent’s unique healthcare challenges. Dr Bairu highlighted that the selected projects offer high-impact, context-driven solutions that target gaps in cancer care, promoting sustainable and locally relevant interventions. AORTIC Access to Innovation Special Interest Group co-chairs Miriam Mutebi and Abiola Ibraheem also praised the depth of talent across Africa and expressed confidence that the cohort’s work would produce evidence-based solutions to improve cancer outcomes in their respective countries.
Dr Swart’s recognition strengthens the University of Botswana’s research footprint and reinforces its strategic focus on producing interdisciplinary, high-impact research that addresses national and continental priorities. The collaborative nature of the project demonstrates the institution’s commitment to fostering partnerships across faculties and leveraging local expertise to generate meaningful outcomes. By positioning African institutions like UB at the forefront of health research, initiatives such as this ensure that solutions to pressing challenges are informed by local knowledge and lived realities. The collaboration between biotechnology company Bio Usawa and AORTIC further supports capacity building and knowledge sharing while enhancing access to life-saving interventions across Africa. The project exemplifies the role of local researchers in shaping policies, improving care delivery, and advancing scientific knowledge in a contextually relevant manner.
Dr Norman Carl Swart’s achievement underscores the University of Botswana’s growing influence in continental health research and its contribution to Africa’s fight against cancer. By securing this prestigious microgrant, Dr Swart and his multidisciplinary team demonstrate the value of locally led, evidence-based approaches to complex health challenges. Their work has the potential to inform policy, strengthen health systems, and improve patient outcomes across the region. The award highlights the importance of supporting African researchers and institutions in generating solutions that are tailored to the continent’s needs. Dr Swart’s recognition serves as a testament to UB’s commitment to research excellence, innovation, and collaboration, positioning Botswana as a key contributor to Africa’s collective response to critical health issues.
